Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Cross-elicitation responses to 2-methoxymethyl-p-phenylenediamine in p-phenylenediamine highly allergic volunteers using allergy alert test: the Italian experience.

Tammaro A, Muscianese M, Chello C, Parisella FR, Persechino S, Goebel C, Gaspari AA.

Eur Ann Allergy Clin Immunol. 2019 Jan 31. doi: 10.23822/EurAnnACI.1764-1489.82. [Epub ahead of print]

PMID:
30702234
2.

Immediate hypersensitivity to p-phenylenediamine.

Wilkinson M, Solman L, Coenraads PJ, Goebel C.

Contact Dermatitis. 2019 Mar;80(3):177-178. doi: 10.1111/cod.13156. Epub 2018 Nov 13. No abstract available.

PMID:
30426523
3.

Allergy Alert Test for p-Phenylenediamine-Allergic Hair Dye Users.

Coenraads PJ, Aberer W, Cristaudo A, Diepgen T, Holden C, Koch L, Schuttelaar ML, Weisshaar E, Fuchs A, Schlotmann K, Goebel C, Blömeke B, Krasteva M.

Dermatitis. 2018 Sep/Oct;29(5):250-257. doi: 10.1097/DER.0000000000000405.

PMID:
30234613
4.

Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors.

Vatner RE, Niemierko A, Misra M, Weyman EA, Goebel CP, Ebb DH, Jones RM, Huang MS, Mahajan A, Grosshans DR, Paulino AC, Stanley T, MacDonald SM, Tarbell NJ, Yock TI.

J Clin Oncol. 2018 Oct 1;36(28):2854-2862. doi: 10.1200/JCO.2018.78.1492. Epub 2018 Aug 17.

5.

The Allergy Alert Test: Introduction of a Protocol Suitable to Provide an Alert Signal in p-Phenylenediamine-Allergic Hair Dye Users.

Coenraads PJ, Aberer W, Cristaudo A, Diepgen T, Holden C, Koch L, Schuttelaar ML, Weisshaar E, Fuchs A, Schlotmann K, Goebel C, Blömeke B, Krasteva M.

Dermatitis. 2018 Aug 9. doi: 10.1097/DER.0000000000000405. [Epub ahead of print]

PMID:
30096055
6.

Cross-elicitation responses to 2-methoxymethyl-p-phenylenediamine in p-phenylenediamine-allergic individuals: Results from open use testing and diagnostic patch testing.

Schuttelaar ML, Dittmar D, Burgerhof JGM, Blömeke B, Goebel C.

Contact Dermatitis. 2018 Nov;79(5):288-294. doi: 10.1111/cod.13078. Epub 2018 Aug 7.

7.

Persulfate Reaction in a Hair-Bleaching Formula: Unveiling the Unconventional Reactivity of 1,13-Diamino-4,7,10-Trioxatridecane.

Gargano EM, Mangiatordi GF, Weber I, Goebel C, Alberga D, Nicolotti O, Ruess W, Wierlacher S.

ChemistryOpen. 2018 Mar 25;7(5):319-322. doi: 10.1002/open.201800013. eCollection 2018 May.

8.

Urine and Serum Sex Steroid Profile in Testosterone-Treated Transgender and Hypogonadal and Healthy Control Men.

Savkovic S, Lim S, Jayadev V, Conway A, Turner L, Curtis D, Goebel C, Handelsman DJ.

J Clin Endocrinol Metab. 2018 Jun 1;103(6):2277-2283. doi: 10.1210/jc.2018-00054.

PMID:
29584875
9.

Skin sensitization quantitative risk assessment for occupational exposure of hairdressers to hair dye ingredients.

Goebel C, Diepgen TL, Blömeke B, Gaspari AA, Schnuch A, Fuchs A, Schlotmann K, Krasteva M, Kimber I.

Regul Toxicol Pharmacol. 2018 Jun;95:124-132. doi: 10.1016/j.yrtph.2018.03.006. Epub 2018 Mar 9.

PMID:
29530615
10.

Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors.

Zureick AH, Evans CL, Niemierko A, Grieco JA, Nichols AJ, Fullerton BC, Hess CB, Goebel CP, Gallotto SL, Weyman EA, Gaudet DE, Nartowicz JA, Ebb DH, Jones RM, MacDonald SM, Tarbell NJ, Yock TI, Pulsifer MB.

Cancer. 2018 May 15;124(10):2238-2245. doi: 10.1002/cncr.31143. Epub 2018 Mar 2.

PMID:
29499085
11.

Non-animal methods to predict skin sensitization (I): the Cosmetics Europe database.

Hoffmann S, Kleinstreuer N, Alépée N, Allen D, Api AM, Ashikaga T, Clouet E, Cluzel M, Desprez B, Gellatly N, Goebel C, Kern PS, Klaric M, Kühnl J, Lalko JF, Martinozzi-Teissier S, Mewes K, Miyazawa M, Parakhia R, van Vliet E, Zang Q, Petersohn D.

Crit Rev Toxicol. 2018 May;48(5):344-358. doi: 10.1080/10408444.2018.1429385. Epub 2018 Feb 23.

PMID:
29474128
12.

Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors.

Gentile MS, Yeap BY, Paganetti H, Goebel CP, Gaudet DE, Gallotto SL, Weyman EA, Morgan ML, MacDonald SM, Giantsoudi D, Adams J, Tarbell NJ, Kooy H, Yock TI.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):719-729. doi: 10.1016/j.ijrobp.2017.11.026. Epub 2017 Nov 23.

PMID:
29413284
13.

Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1.

Saygin C, Hirsch C, Przychodzen B, Sekeres MA, Hamilton BK, Kalaycio M, Carraway HE, Gerds AT, Mukherjee S, Nazha A, Sobecks R, Goebel C, Abounader D, Maciejewski JP, Advani AS.

Blood Cancer J. 2018 Jan 10;8(1):4. doi: 10.1038/s41408-017-0040-9.

14.

Application of in vitro skin penetration measurements to confirm and refine the quantitative skin sensitization risk assessment of methylisothiazolinone.

Rothe H, Ryan CA, Page L, Vinall J, Goebel C, Scheffler H, Toner F, Roper C, Kern PS.

Regul Toxicol Pharmacol. 2017 Dec;91:197-207. doi: 10.1016/j.yrtph.2017.10.024. Epub 2017 Nov 6.

PMID:
29080845
15.

State-of-the-art and new options to assess T cell activation by skin sensitizers: Cosmetics Europe Workshop.

van Vliet E, Kühnl J, Goebel C, Martinozzi-Teissier S, Alépée N, Ashikaga T, Blömeke B, Del Bufalo A, Cluzel M, Corsini E, Delrue N, Desprez B, Gellatly N, Giese C, Gribaldo L, Hoffmann S, Klaric M, Maillere B, Naisbitt D, Pallardy M, Vocanson M, Petersohn D.

ALTEX. 2018;35(2):179-192. doi: 10.14573/altex.1709011. Epub 2017 Oct 2.

16.

Referral processes and wait times in primary care.

Neimanis I, Gaebel K, Dickson R, Levy R, Goebel C, Zizzo A, Woods A, Corsini J.

Can Fam Physician. 2017 Aug;63(8):619-624.

17.

DMSO Assisted Electrospray Ionization for the Detection of Small Peptide Hormones in Urine by Dilute-and-Shoot-Liquid-Chromatography-High Resolution Mass Spectrometry.

Judák P, Grainger J, Goebel C, Van Eenoo P, Deventer K.

J Am Soc Mass Spectrom. 2017 Aug;28(8):1657-1665. doi: 10.1007/s13361-017-1670-7. Epub 2017 Apr 19.

PMID:
28425052
18.

Role of family physicians in an urban hospital: Tracking changes between 1977, 1997, and 2014.

Neimanis I, Woods A, Zizzo A, Dickson R, Levy R, Goebel C, Corsini J, Burns S, Gaebel K.

Can Fam Physician. 2017 Mar;63(3):221-227.

19.
20.

[Lymphadenitis and systemic lupus erythematosus].

Merwald-Fraenk H, Wiesent F, Dörfler R, Goebel C.

Z Rheumatol. 2016 Dec;75(10):1028-1031. German.

PMID:
27696314
21.

The role of HIF-1 in oncostatin M-dependent metabolic reprogramming of hepatic cells.

Battello N, Zimmer AD, Goebel C, Dong X, Behrmann I, Haan C, Hiller K, Wegner A.

Cancer Metab. 2016 Feb 17;4:3. doi: 10.1186/s40170-016-0141-0. eCollection 2016.

22.

The role of the antioxidant ascorbic acid in the elicitation of contact allergic reactions to p-phenylenediamine.

Coenraads PJ, Vogel TA, Blömeke B, Goebel C, Roggeband R, Schuttelaar ML.

Contact Dermatitis. 2016 May;74(5):267-72. doi: 10.1111/cod.12535. Epub 2016 Feb 15.

PMID:
26875881
23.

Continuous usage of a hair dye product containing 2-methoxymethyl-para-phenylenediamine by hair-dye-allergic individuals.

Kock M, Coenraads PJ, Blömeke B, Goebel C.

Br J Dermatol. 2016 May;174(5):1042-50. doi: 10.1111/bjd.14390. Epub 2016 Mar 27.

PMID:
26749506
24.

Suitability of the in vitro Caco-2 assay to predict the oral absorption of aromatic amine hair dyes.

Obringer C, Manwaring J, Goebel C, Hewitt NJ, Rothe H.

Toxicol In Vitro. 2016 Apr;32:1-7. doi: 10.1016/j.tiv.2015.11.007. Epub 2015 Nov 12.

25.

COMPARISON BETWEEN FOUR USUAL METHODS OF IDENTIFICATION OF Candida SPECIES.

Souza MN, Ortiz SO, Mello MM, Oliveira Fde M, Severo LC, Goebel CS.

Rev Inst Med Trop Sao Paulo. 2015 Jul-Aug;57(4):281-7. doi: 10.1590/S0036-46652015000400002.

26.

Doping in sport and exercise: anabolic, ergogenic, health and clinical issues.

Bird SR, Goebel C, Burke LM, Greaves RF.

Ann Clin Biochem. 2016 Mar;53(Pt 2):196-221. doi: 10.1177/0004563215609952. Epub 2015 Sep 17. Review.

PMID:
26384361
27.

Extrapolation of systemic bioavailability assessing skin absorption and epidermal and hepatic metabolism of aromatic amine hair dyes in vitro.

Manwaring J, Rothe H, Obringer C, Foltz DJ, Baker TR, Troutman JA, Hewitt NJ, Goebel C.

Toxicol Appl Pharmacol. 2015 Sep 1;287(2):139-148. doi: 10.1016/j.taap.2015.05.016. Epub 2015 May 29.

28.

Polyarteritis nodosa causing a vast coronary artery aneurysm.

Ebersberger U, Rieber J, Wellmann P, Goebel C, Gansera B.

J Am Coll Cardiol. 2015 Feb 10;65(5):e1-2. doi: 10.1016/j.jacc.2013.08.1667. No abstract available.

29.

Optimum insufflation capacity and peak cough flow in neuromuscular disorders.

Mellies U, Goebel C.

Ann Am Thorac Soc. 2014 Dec;11(10):1560-8. doi: 10.1513/AnnalsATS.201406-264OC.

PMID:
25384211
30.

N,N-dimethyl-2-phenylpropan-1-amine - new designer agent found in athlete urine and nutritional supplement.

Kwiatkowska D, Wójtowicz M, Jarek A, Goebel C, Chajewska K, Turek-Lepa E, Pokrywka A, Kazlauskas R.

Drug Test Anal. 2015 Apr;7(4):331-5. doi: 10.1002/dta.1741. Epub 2014 Oct 29.

PMID:
25355281
31.

Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma.

Ladra MM, Szymonifka JD, Mahajan A, Friedmann AM, Yong Yeap B, Goebel CP, MacDonald SM, Grosshans DR, Rodriguez-Galindo C, Marcus KJ, Tarbell NJ, Yock TI.

J Clin Oncol. 2014 Nov 20;32(33):3762-70. doi: 10.1200/JCO.2014.56.1548. Epub 2014 Oct 20. Erratum in: J Clin Oncol. 2015 Jan 10;33(2):228.

32.

Committee on Utilization, Review, and Education common referral form.

Neimanis I, Gaebel K, Dickson RC, Levy R, Goebel C, Zizzo AJ, Woods A, Corsini J.

Can Fam Physician. 2014 Oct;60(10):916. No abstract available.

33.

Cross-elicitation responses to 2-methoxymethyl-p-phenylenediamine under hair dye use conditions in p-phenylenediamine-allergic individuals.

Blömeke B, Pot LM, Coenraads PJ, Hennen J, Kock M, Goebel C.

Br J Dermatol. 2015 Apr;172(4):976-80. doi: 10.1111/bjd.13412. Epub 2015 Feb 26.

PMID:
25234507
34.

Stable carbon isotope ratio profiling of illicit testosterone preparations--domestic and international seizures.

Brooker L, Cawley A, Drury J, Edey C, Hasick N, Goebel C.

Drug Test Anal. 2014 Oct;6(10):996-1001. doi: 10.1002/dta.1533. Epub 2014 Aug 19.

PMID:
25139646
35.

Assessment of the elicitation response in subjects weakly sensitized to p-phenylenediamine.

Pot LM, Coenraads PJ, Goebel C, Blömeke B.

Br J Dermatol. 2015 Jan;172(1):138-44. doi: 10.1111/bjd.13142. Epub 2014 Dec 8.

PMID:
24890083
36.

Extrahepatic metabolism at the body's internal-external interfaces.

Gundert-Remy U, Bernauer U, Blömeke B, Döring B, Fabian E, Goebel C, Hessel S, Jäckh C, Lampen A, Oesch F, Petzinger E, Völkel W, Roos PH.

Drug Metab Rev. 2014 Aug;46(3):291-324. doi: 10.3109/03602532.2014.900565. Epub 2014 Mar 25. Review.

PMID:
24666398
37.

Detection and effects on serum and urine steroid and LH of repeated GnRH analog (leuprolide) stimulation.

Handelsman DJ, Idan A, Grainger J, Goebel C, Turner L, Conway AJ.

J Steroid Biochem Mol Biol. 2014 May;141:113-20. doi: 10.1016/j.jsbmb.2014.01.011. Epub 2014 Feb 2.

PMID:
24495617
38.

Categorization of chemicals according to their relative human skin sensitizing potency.

Basketter DA, Alépée N, Ashikaga T, Barroso J, Gilmour N, Goebel C, Hibatallah J, Hoffmann S, Kern P, Martinozzi-Teissier S, Maxwell G, Reisinger K, Sakaguchi H, Schepky A, Tailhardat M, Templier M.

Dermatitis. 2014 Jan-Feb;25(1):11-21. doi: 10.1097/DER.0000000000000003. Review.

PMID:
24407057
39.

A sustainable template for mesoporous zeolite synthesis.

White RJ, Fischer A, Goebel C, Thomas A.

J Am Chem Soc. 2014 Feb 19;136(7):2715-8. doi: 10.1021/ja411586h. Epub 2014 Feb 7.

PMID:
24397534
40.

Introduction of a methoxymethyl side chain into p-phenylenediamine attenuates its sensitizing potency and reduces the risk of allergy induction.

Goebel C, Troutman J, Hennen J, Rothe H, Schlatter H, Gerberick GF, Blömeke B.

Toxicol Appl Pharmacol. 2014 Feb 1;274(3):480-7. doi: 10.1016/j.taap.2013.11.016. Epub 2013 Dec 10.

PMID:
24333256
41.

Memantine in patients with moderate to severe Alzheimer's disease: meta-analyses using realistic definitions of response.

Wilkinson D, Wirth Y, Goebel C.

Dement Geriatr Cogn Disord. 2014;37(1-2):71-85. doi: 10.1159/000353801. Epub 2013 Oct 3. Review.

PMID:
24107324
42.

Cyanamide route to calcium-manganese oxide foams for water oxidation.

Baktash E, Zaharieva I, Schröder M, Goebel C, Dau H, Thomas A.

Dalton Trans. 2013 Dec 28;42(48):16920-9. doi: 10.1039/c3dt51693h. Epub 2013 Oct 4.

PMID:
24091767
43.

The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse.

Banister SD, Wilkinson SM, Longworth M, Stuart J, Apetz N, English K, Brooker L, Goebel C, Hibbs DE, Glass M, Connor M, McGregor IS, Kassiou M.

ACS Chem Neurosci. 2013 Jul 17;4(7):1081-92. doi: 10.1021/cn400035r. Epub 2013 Apr 17.

44.

Use of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations.

Hewitt NJ, Edwards RJ, Fritsche E, Goebel C, Aeby P, Scheel J, Reisinger K, Ouédraogo G, Duche D, Eilstein J, Latil A, Kenny J, Moore C, Kuehnl J, Barroso J, Fautz R, Pfuhler S.

Toxicol Sci. 2013 Jun;133(2):209-17. doi: 10.1093/toxsci/kft080. Epub 2013 Mar 28.

PMID:
23539547
45.

Self-reported physician adherence to guidelines for measuring blood pressure.

Dickson RC, Gaebel K, Zizzo A, Neimanis I, Bridge M, Corsini J, Goebel C, Levy R, Woods A.

J Am Board Fam Med. 2013 Mar-Apr;26(2):215-7. doi: 10.3122/jabfm.2013.02.120024.

46.

Quantitative risk assessment for skin sensitisation: consideration of a simplified approach for hair dye ingredients.

Goebel C, Diepgen TL, Krasteva M, Schlatter H, Nicolas JF, Blömeke B, Coenraads PJ, Schnuch A, Taylor JS, Pungier J, Fautz R, Fuchs A, Schuh W, Gerberick GF, Kimber I.

Regul Toxicol Pharmacol. 2012 Dec;64(3):459-65. doi: 10.1016/j.yrtph.2012.10.004. Epub 2012 Oct 13.

PMID:
23069142
47.

Carbon isotope ratio analysis of endogenous glucocorticoid urinary metabolites after cortisone acetate and adrenosterone administration for doping control.

Brooker L, Cawley A, Kazlauskas R, Goebel C, George A.

Drug Test Anal. 2012 Dec;4(12):951-61. doi: 10.1002/dta.1403. Epub 2012 Sep 17.

PMID:
22987608
48.

Xenobiotic metabolism capacities of human skin in comparison with a 3D-epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: phase II enzymes.

Götz C, Pfeiffer R, Tigges J, Ruwiedel K, Hübenthal U, Merk HF, Krutmann J, Edwards RJ, Abel J, Pease C, Goebel C, Hewitt N, Fritsche E.

Exp Dermatol. 2012 May;21(5):364-9. doi: 10.1111/j.1600-0625.2012.01478.x.

PMID:
22509834
49.

Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I).

Götz C, Pfeiffer R, Tigges J, Blatz V, Jäckh C, Freytag EM, Fabian E, Landsiedel R, Merk HF, Krutmann J, Edwards RJ, Pease C, Goebel C, Hewitt N, Fritsche E.

Exp Dermatol. 2012 May;21(5):358-63. doi: 10.1111/j.1600-0625.2012.01486.x.

PMID:
22509833
50.

Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: skin sensitisation.

Goebel C, Aeby P, Ade N, Alépée N, Aptula A, Araki D, Dufour E, Gilmour N, Hibatallah J, Keller D, Kern P, Kirst A, Marrec-Fairley M, Maxwell G, Rowland J, Safford B, Schellauf F, Schepky A, Seaman C, Teichert T, Tessier N, Teissier S, Weltzien HU, Winkler P, Scheel J.

Regul Toxicol Pharmacol. 2012 Jun;63(1):40-52. doi: 10.1016/j.yrtph.2012.02.007. Epub 2012 Feb 21.

Supplemental Content

Loading ...
Support Center